Barkholt, L. Et Al. 2009. Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study. IMMUNOTHERAPY , vol.1, no.5 , 753-764.

Barkholt, L., Alici, E., Conrad, R., Sutlu, T., Gilljam, M., Stellan, B., ... Christensson, B.(2009). Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study. IMMUNOTHERAPY , vol.1, no.5, 753-764.

Barkholt, L. Et Al. "Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study," IMMUNOTHERAPY , vol.1, no.5, 753-764, 2009

Barkholt, L. Et Al. "Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study." IMMUNOTHERAPY , vol.1, no.5, pp.753-764, 2009

Barkholt, L. Et Al. (2009) . "Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study." IMMUNOTHERAPY , vol.1, no.5, pp.753-764.

@article{article, author={L. Barkholt Et Al. }, title={Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study}, journal={IMMUNOTHERAPY}, year=2009, pages={753-764} }